Randomized Placebo Controlled Double Blind Study of Restasis Versus Placebo in Primary Prevention of Ocular GVHD After Allogeneic Stem Cell Transplantation.
Phase of Trial: Phase III
Latest Information Update: 09 Mar 2017
At a glance
- Drugs Ciclosporin (Primary)
- Indications Graft-versus-host disease
- Focus Therapeutic Use
- 14 Oct 2016 Status changed from active, no longer recruiting to completed.
- 13 May 2013 Planned end date changed from 1 Jan 2016 to 1 Jul 2016 as reported by ClinicalTrials.gov.
- 08 Aug 2012 Planned end date changed from 1 Jul 2015 to 1 Jan 2016 as reported by ClinicalTrials.go